Clinical Decision Support System for Depression

Temple University, Philadelphia, PA
DepressionClinical Decision Support System - Device
All Sexes

Study Summary

This trial will test a new digital health platform to help doctors treat patients with depression. The goal is to see if it improves patient outcomes.

Eligible Conditions
  • Depression

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: 3 months

3 months
Effectiveness in Reduction of Depression Symptoms
Medication Adherence Rates
Number of ER visits, admissions, and re-admissions
Patient Disability with WHODAS rating scale
Patient Questionnaire Response Rate
Rate of Safety - Adverse Events
Response Rate
Time to Remission

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Active Control
1 of 2
Active Intervention
1 of 2

Active Control

Experimental Treatment

500 Total Participants · 2 Treatment Groups

Primary Treatment: Clinical Decision Support System · No Placebo Group · N/A

Active Intervention
Experimental Group · 1 Intervention: Clinical Decision Support System · Intervention Types: Device
Active Control
ActiveComparator Group · 1 Intervention: Clinical Decision Support System · Intervention Types: Device
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinical Decision Support System

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months

Who is running the clinical trial?

McDougall ScientificUNKNOWN
Stiris ResearchUNKNOWN
Aifred HealthLead Sponsor
McGill UniversityOTHER
369 Previous Clinical Trials
978,256 Total Patients Enrolled
14 Trials studying Depression
2,221 Patients Enrolled for Depression

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
How old are they?
18 - 6575.0%
What site did they apply to?
Yale University, VA Connecticut Healthcare System25.0%
Sarkis Clinical Trials, Inc.25.0%
Emory University25.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria20.0%
Met criteria80.0%
Why did patients apply to this trial?
  • "I've finally decided to love forward in addressing my medical condition of depression. I was against using the pharmaceutical drugs but now am a bit open to us now to solve my depression."
How many prior treatments have patients received?

Frequently Asked Questions

How many healthcare facilities are currently involved in the implementation of this trial?

"This trial is conducted in Douglas Mental Health University Institute (Verdun, Quebec), GMF Centre Médical Métro Monk (Montréal, Ontario), McGill University Health Care Centre (MUHC) in Toronto, Vermont and 16 other medical institutions." - Anonymous Online Contributor

Unverified Answer

How many individuals are being observed in this clinical trial?

"Affirmative. The website reflects that this trial, which was inaugurated on June 16th 2022 is currently recruiting participants. In total, the study requires 500 people from 16 locations to take part in the research." - Anonymous Online Contributor

Unverified Answer

Are recruitment efforts for this experiment ongoing?

"Affirmative. displays that this research is presently enrolling patients; the trial was first made available on June 16th 2022, and last modified on September 26th 2022. The study requires 500 participants between 16 different sites to complete it" - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.